Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines
- PMID: 12885890
- PMCID: PMC167215
- DOI: 10.1128/jvi.77.16.8712-8718.2003
Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines
Abstract
Marek's disease (MD), a highly infectious disease caused by an oncogenic herpesvirus, is one of the few herpesvirus diseases against which live attenuated vaccines are used as the main strategy for control. We have constructed bacterial artificial chromosomes (BACs) of the CVI988 (Rispens) strain of the virus, the most widely used and effective vaccine against MD. Viruses derived from the BAC clones were stable after in vitro and in vivo passages and showed characteristics and growth kinetics similar to those of the parental virus. Molecular analysis of the individual BAC clones showed differences in the structure of the meq gene, indicating that the commercial vaccine contains virus populations with distinct genomic structures. We also demonstrate that, contrary to the published data, the sequence of the L-meq of the BAC clone did not show any frameshift. Virus stocks derived from one of the BAC clones (clone 10) induced 100 percent protection against infection by the virulent strain RB1B, indicating that BAC-derived viruses could be used with efficacies similar to those of the parental CVI988 vaccines. As a DNA vaccine, this BAC clone was also able to induce protection in 6 of 20 birds. Isolation of CVI988 virus from all of these six birds suggested that immunity against challenge was probably dependent on the reconstitution of the virus in vivo and that such viruses are also as immunogenic as the in vitro-grown BAC-derived or parental vaccine viruses. Although the reasons for the induction of protection only in a proportion of birds (33.3%) that received the DNA vaccine are not clear, this is most likely to be related to the suboptimal method of DNA delivery. The construction of the CVI988 BAC is a major step towards understanding the superior immunogenic features of CVI988 and provides the opportunity to exploit the power of BAC technology for generation of novel molecularly defined vaccines.
Figures
Similar articles
-
A MEQ-deleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine.Avian Dis. 2010 Jun;54(2):862-9. doi: 10.1637/9048-090409-Reg.1. Avian Dis. 2010. PMID: 20608531 Clinical Trial.
-
Vaccinal efficacy of molecularly cloned Gallid alphaherpesvirus 3 strain 301B/1 against very virulent Marek's disease virus challenge.J Gen Virol. 2020 May;101(5):542-552. doi: 10.1099/jgv.0.001403. Epub 2020 Mar 5. J Gen Virol. 2020. PMID: 32134378
-
Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain.Virol J. 2013 Nov 6;10:328. doi: 10.1186/1743-422X-10-328. Virol J. 2013. PMID: 24195756 Free PMC article.
-
Marek's disease virus research in the post-sequencing era: new tools for the study of gene functions and virus-host interactions.Avian Pathol. 2003 Aug;32(4):323-33. doi: 10.1080/0307945031000121068. Avian Pathol. 2003. PMID: 17585455 Review.
-
Prevention of Marek's disease: a review.Cancer Res. 1976 Feb;36(2 pt 2):696-700. Cancer Res. 1976. PMID: 766959 Review.
Cited by
-
Dynamic Changes in Viral Loads during Co-Infection with a Recombinant Turkey Herpesvirus Vector Vaccine and Very Virulent Marek's Disease Virus In Vivo.Viruses. 2024 Jun 27;16(7):1042. doi: 10.3390/v16071042. Viruses. 2024. PMID: 39066205 Free PMC article.
-
Comparative analysis of multiple consensus genomes of the same strain of Marek's disease virus reveals intrastrain variation.Virus Evol. 2024 Jun 21;10(1):veae047. doi: 10.1093/ve/veae047. eCollection 2024. Virus Evol. 2024. PMID: 39036034 Free PMC article.
-
Differential Replication and Cytokine Response between Vaccine and Very Virulent Marek's Disease Viruses in Spleens and Bursas during Latency and Reactivation.Viruses. 2022 Dec 20;15(1):6. doi: 10.3390/v15010006. Viruses. 2022. PMID: 36680047 Free PMC article.
-
The Role of Dendritic Cells in the Host Response to Marek's Disease Virus (MDV) as Shown by Transcriptomic Analysis of Susceptible and Resistant Birds.Pathogens. 2022 Nov 13;11(11):1340. doi: 10.3390/pathogens11111340. Pathogens. 2022. PMID: 36422592 Free PMC article.
-
Efficient Mutagenesis of Marek's Disease Virus-Encoded microRNAs Using a CRISPR/Cas9-Based Gene Editing System.Viruses. 2020 Apr 20;12(4):466. doi: 10.3390/v12040466. Viruses. 2020. PMID: 32325942 Free PMC article.
References
-
- Brune, W., M. Messerle, and U. H. Koszinowski. 2000. Forward with BACs: new tools for herpesvirus genomics. Trends Genet. 16:254-259. - PubMed
-
- Chang, K. S., S. I. Lee., K. Ohashi, A. Ibrahim, and M. Onuma. 2002. The detection of the meq gene in chicken infected with Marek's disease virus serotype 1. J. Vet. Med. Sci. 64:413-417. - PubMed
-
- Cui, Z. Z., A. Qin., L. F. Lee, P. Wu, and H. J. Kung. 1999. Construction and characterisation of a H19 epitope point mutant of MDV CVI988/Rispens strain. Acta Virol. 43:169-173. - PubMed
-
- Davidson, I., R. Borenshtain, and Y. Weisman. 2002. Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens. J. Vet. Med. 49:83-87. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials